Heterogeneity of triple-negative breast cancer was examined and compared across morphologic and molecular features Routine pathologic sections of triple negative breast cancer were examined and cases
Fresh tumor biopsies were prospectively obtained from 50 patients diagnosed with clinical stage II-III TNBC defined as ER-, PR-, and HER2-negative. Briefly, frozen tissue samples were washed with cold
